Lipid Profiles, Telomere Length, and the Risk of Malignant Tumors: A Mendelian Randomization and Mediation Analysis

Overview

Journal Biomedicines

Date 2025 Jan 25

PMID 39857597

Authors

Shupeng Liu

Zhengzheng Fu

Hui Liu

Yinghui Wang

Meijuan Zhou

Zhenhua Ding

Zhijun Feng

Affiliations

Soon will be listed here.

Abstract

The relationship between lipid profiles, telomere length (TL), and cancer risk remains unclear. This study employed two-sample Mendelian randomization (MR) with mediation analysis to investigate their causal relationships, examining lipid profiles as exposure, TL as mediator, and nine cancer types as outcomes. We conducted our analysis using two-stage least squares (2SLS) regression integrated with inverse variance weighted (IVW) methods to address potential endogeneity and strengthen our causal inference. we found that unfavorable lipid profiles were causally linked to increased TL ( < 0.05). TL showed positive causal associations with lung and hematologic cancers (OR > 1, < 0.05). Direct associations were observed between total and low-density lipoprotein (LDL) cholesterol and gastric cancer (OR < 1, < 0.05), and between remnant cholesterol and colorectal cancer (OR > 1, < 0.05). Mediation analysis revealed TL as a significant mediator in the pathway from lipid profiles to cancer development ( < 0.05). No horizontal pleiotropy was detected. Our findings suggest that lipid metabolism disorders may influence cancer development through telomere regulation, particularly in lung and hematologic cancers. This emphasizes the importance of lipid management in cancer prevention and treatment, especially for these cancer types.

References

Codd V, Wang Q, Allara E, Musicha C, Kaptoge S, Stoma S . Polygenic basis and biomedical consequences of telomere length variation. Nat Genet. 2021; 53(10):1425-1433. PMC: 8492471. DOI: 10.1038/s41588-021-00944-6. View

Snaebjornsson M, Janaki-Raman S, Schulze A . Greasing the Wheels of the Cancer Machine: The Role of Lipid Metabolism in Cancer. Cell Metab. 2019; 31(1):62-76. DOI: 10.1016/j.cmet.2019.11.010. View

Xie R, Xie H, Gao H, Xie C, Yuan H, Feng Z . Mitochondrial proteins as therapeutic targets in diabetic ketoacidosis: evidence from Mendelian randomization analysis. Front Pharmacol. 2024; 15:1448505. PMC: 11513349. DOI: 10.3389/fphar.2024.1448505. View

Kronenberg F . Telomere length and chronic kidney disease: cause or consequence?. Kidney Int. 2021; 100(5):980-983. DOI: 10.1016/j.kint.2021.08.013. View

Zhang T, Guo Z, Huo X, Gong Y, Li C, Huang J . Dysregulated lipid metabolism blunts the sensitivity of cancer cells to EZH2 inhibitor. EBioMedicine. 2022; 77:103872. PMC: 8850333. DOI: 10.1016/j.ebiom.2022.103872. View

Burgess S, Butterworth A, Thompson S . Mendelian randomization analysis with multiple genetic variants using summarized data. Genet Epidemiol. 2013; 37(7):658-65. PMC: 4377079. DOI: 10.1002/gepi.21758. View

Zugna D, Popovic M, Fasanelli F, Heude B, Scelo G, Richiardi L . Applied causal inference methods for sequential mediators. BMC Med Res Methodol. 2022; 22(1):301. PMC: 9686042. DOI: 10.1186/s12874-022-01764-w. View

Bowden J, Davey Smith G, Haycock P, Burgess S . Consistent Estimation in Mendelian Randomization with Some Invalid Instruments Using a Weighted Median Estimator. Genet Epidemiol. 2016; 40(4):304-14. PMC: 4849733. DOI: 10.1002/gepi.21965. View

Liu D, Gao X, Pan X, Zhou T, Zhu C, Li F . The hepato-ovarian axis: genetic evidence for a causal association between non-alcoholic fatty liver disease and polycystic ovary syndrome. BMC Med. 2023; 21(1):62. PMC: 9940436. DOI: 10.1186/s12916-023-02775-0. View

10.

Harrison S, Holmes M, Burgess S, Asselbergs F, Jones G, Baas A . Genetic Association of Lipids and Lipid Drug Targets With Abdominal Aortic Aneurysm: A Meta-analysis. JAMA Cardiol. 2017; 3(1):26-33. PMC: 5833524. DOI: 10.1001/jamacardio.2017.4293. View

11.

Feng Z, Wang Y, Fu Z, Liao J, Liu H, Zhou M . Exploring the Causal Effects of Mineral Metabolism Disorders on Telomere and Mitochondrial DNA: A Bidirectional Two-Sample Mendelian Randomization Analysis. Nutrients. 2024; 16(10). PMC: 11123946. DOI: 10.3390/nu16101417. View

12.

Miller K, Siegel R, Lin C, Mariotto A, Kramer J, Rowland J . Cancer treatment and survivorship statistics, 2016. CA Cancer J Clin. 2016; 66(4):271-89. DOI: 10.3322/caac.21349. View

13.

Crouse W, Keele G, Gastonguay M, Churchill G, Valdar W . A Bayesian model selection approach to mediation analysis. PLoS Genet. 2022; 18(5):e1010184. PMC: 9129027. DOI: 10.1371/journal.pgen.1010184. View

14.

Byrska-Bishop M, Evani U, Zhao X, Basile A, Abel H, Regier A . High-coverage whole-genome sequencing of the expanded 1000 Genomes Project cohort including 602 trios. Cell. 2022; 185(18):3426-3440.e19. PMC: 9439720. DOI: 10.1016/j.cell.2022.08.004. View

15.

Liu X, Liang Y, Song R, Yang G, Han J, Lan Y . Long non-coding RNA NEAT1-modulated abnormal lipolysis via ATGL drives hepatocellular carcinoma proliferation. Mol Cancer. 2018; 17(1):90. PMC: 5953401. DOI: 10.1186/s12943-018-0838-5. View

16.

Burgess S, Thompson S . Interpreting findings from Mendelian randomization using the MR-Egger method. Eur J Epidemiol. 2017; 32(5):377-389. PMC: 5506233. DOI: 10.1007/s10654-017-0255-x. View

17.

Pavlova N, Zhu J, Thompson C . The hallmarks of cancer metabolism: Still emerging. Cell Metab. 2022; 34(3):355-377. PMC: 8891094. DOI: 10.1016/j.cmet.2022.01.007. View

18.

Cheng C, Geng F, Cheng X, Guo D . Lipid metabolism reprogramming and its potential targets in cancer. Cancer Commun (Lond). 2018; 38(1):27. PMC: 5993136. DOI: 10.1186/s40880-018-0301-4. View

19.

Zhou X, Lian P, Liu H, Wang Y, Zhou M, Feng Z . Causal Associations between Gut Microbiota and Different Types of Dyslipidemia: A Two-Sample Mendelian Randomization Study. Nutrients. 2023; 15(20). PMC: 10609956. DOI: 10.3390/nu15204445. View

20.

Zhang Y, Li T, Pan M, Wang W, Huang W, Yuan Y . SIRT1 prevents cigarette smoking-induced lung fibroblasts activation by regulating mitochondrial oxidative stress and lipid metabolism. J Transl Med. 2022; 20(1):222. PMC: 9107262. DOI: 10.1186/s12967-022-03408-5. View